New study finds that elevated S100A8/A9 levels in blood may be associated with cognitive impairment in adults with #lupus.

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in ...

In this randomized trial, obinutuzumab plus standard therapy was more efficacious than standard therapy alone in providing a ...

The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...

Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.

Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

Riya began to get "off" feelings at the age of 22. Her symptoms were subtle: body aches, periodic low-grade fevers, fatigue ...

The following is a summary of “2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and ...

Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins ...

AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery ...

Nkarta Inc. (NASDAQ:NKTX) on Wednesday reported a first-quarter loss of 43 cents per share, beating the consensus loss of 44 ...

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study ...